Nonalcoholic Fatty Liver Disease

Resource Center

News
News
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

Featured

multidisciplinary management
Dr Harrison
multidisciplinary management
Collaboration Between Specialists and PCPs in NAFLD Management
05/20/2022
Dr Harrison discusses how specialists can help educate PCPs on NAFLD, the importance of PCPs recognizing which individuals with NAFLD can progress to more severe liver disease, and more.
05/20/2022
diagnosis and management
liver
diagnosis and management
AHA Releases First Scientific Statement on NAFLD, ASCVD
04/28/2022
Nonalcoholic fatty liver disease is estimated to occur in 1 in 4 adults worldwide but understanding of the disease and associated complications is lacking. The American Heart Association recently released a...
04/28/2022
Nonalcoholic Fatty Liver Disease
Nonalcoholic Fatty Liver Disease
Pop Quiz: Contributors to Progressive Disease
04/23/2022
It is common for patients with nonalcoholic fatty liver disease to progress to nonalcoholic steatohepatitis. Do you know which factors contribute to progression? Take our pop quiz to find out!
04/23/2022

Interactive Features

Nonalcoholic Fatty Liver Disease
Nonalcoholic Fatty Liver Disease
Pop Quiz: Contributors to Progressive Disease
04/23/2022
It is common for patients with nonalcoholic fatty liver disease to progress to nonalcoholic steatohepatitis. Do you know which factors contribute to progression? Take our pop quiz to find out!
04/23/2022
Cardiometabolic risk
Cardiometabolic risk
Poll: Liver Disease and CVD
07/02/2020
It has been unclear whether nonalcoholic fatty liver disease is directly related to cardiovascular disease or whether this relationship is confounded by metabolic factors of NAFLD and CVD. What do you...
07/02/2020
Liver Disease
Liver Disease
Pop Quiz: Progression of NAFLD
06/30/2020
Do you know the percentage of patients with nonalcoholic fatty liver disease who will develop progressive disease? Test your knowledge with our pop quiz!
06/30/2020
Liver Disease
Liver Disease
Pop Quiz: Hepatic Portal System
06/30/2020
The gut microbiome affects the development and progression of nonalcoholic fatty liver disease. Do you know which part of the hepatic portal system connects the liver with the intestine?
06/30/2020
Hepatology
Hepatology
Pop Quiz: Global Burden of NAFLD
06/30/2020
In recent years, the obesity pandemic has contributed to an increase in prevalence of nonalcoholic fatty liver disease, though body mass index is only one risk factor. Do you know the estimated global...
06/30/2020

Clinical Insights

multidisciplinary management
Dr Harrison
multidisciplinary management
Collaboration Between Specialists and PCPs in NAFLD Management
05/20/2022
Dr Harrison discusses how specialists can help educate PCPs on NAFLD, the importance of PCPs recognizing which individuals with NAFLD can progress to more severe liver disease, and more.
05/20/2022
Nonalcoholic Fatty Liver Disease
Nonalcoholic Fatty Liver Disease
Wanqing Liu, PhD, on NAFLD, Type 2 Diabetes, and Obesity
10/27/2021
Researchers conducted a study of genomic data to clarify the relationships among nonalcoholic fatty liver disease, type 2 diabetes, and obesity. Lead author Wanqing Liu, PhD, answered our questions about...
10/27/2021
NAFLD
steven grinspoon
NAFLD
Steven Grinspoon, MD, on Steatosis and HIV Take-Home Messages and Next Steps
03/29/2021
In this video, Steven Grinspoon, MD, talks about the overall take-home messages from his session Mechanisms and Treatments for Steatosis in HIV, including what's next for research on this topic.
03/29/2021
NAFLD
Steven Grinspoon, MD
NAFLD
Steven Grinspoon, MD, on the Importance of Studying Treatments for Steatosis in HIV
03/26/2021
In this video, Steven Grinspoon, MD, talks about why treatments for steatosis in HIV are important to study, including some reasons why most studies in nonalcoholic fatty liver disease (NAFLD) do not...
03/26/2021
NAFLD
Steven Grinspoon, MD
NAFLD
Steven Grinspoon, MD, on Effective Treatments of Steatosis in Patients With HIV
03/12/2021
In this video, Steven Grinspoon, MD, speaks about effective treatments of steatosis in patients with HIV, including whether tesamorelin could decrease liver fat in men and women living with HIV and...
03/12/2021